![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
1. 3-amino-9,13b-dihydro-1h-benz(c,f)imidazo(1,5a)azepine
2. Epinastine
3. Flurinol
4. Wal 80
5. Wal 801
6. Wal 801 Cl
7. Wal 801cl
8. Wal-80 Cl
1. Epinastine Hcl
2. 108929-04-0
3. Alesion
4. Elestat
5. Wal-801cl
6. 80012-44-8
7. Wal 801 Cl
8. Epinastine Hydrochloride [jan]
9. De-114
10. Epinastine (hydrochloride)
11. Epinastinehydrochloride
12. Gfm415s5xl
13. Wal-802-cl
14. Wal801
15. Relestat
16. 3-amino-9,13b-dihydro-1h-dibenzo[c,f]imidazo[1,5-a]azepine Hydrochloride
17. 9,13b-dihydro-1h-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine Hydrochloride
18. Dsstox_cid_26502
19. Dsstox_rid_81671
20. Dsstox_gsid_46502
21. Epinastine Hydrochloride (jan)
22. Epinastine Monohydrochloride
23. Chebi:51037
24. Cas-108929-04-0
25. Ncgc00165791-02
26. Unii-gfm415s5xl
27. Flurinol
28. (13brs)-9,13b-dihydro-1h-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine Hydrochloride
29. Alesion (tn)
30. Elestat (tn)
31. Mfcd00933434
32. Epinastin Hydrochloride
33. 9,13b-dihydro-1h-dibenz[cf]imidazo[1,5-a]azepine Hydrochloride
34. Wal-801cl Hcl
35. 3-amino-9,13b-dihydro-1h-dibenz(c,f)imidazo(1,5-a)azepine Monohydrochloride
36. Schembl122749
37. Chembl1200491
38. Dtxsid1046502
39. Epinastine For System Suitability
40. Hy-b0640a
41. Hms3652n21
42. Hms3885b15
43. Bcp12119
44. Ex-a1004
45. Tox21_112263
46. Tox21_500501
47. Epinastine Hydrochloride [mi]
48. S4253
49. Akos015967222
50. Tox21_112263_1
51. Ac-1491
52. Ccg-221805
53. Ks-1159
54. Lp00501
55. Epinastine Hydrochloride [mart.]
56. Ih-dibenz(c,f)imidazo(1,5-a)azepin-3-amine, 9,13b-dihydro-, Monohydrochloride
57. Epinastine Hydrochloride [usp-rs]
58. Epinastine Hydrochloride [who-dd]
59. Ncgc00165791-04
60. Ncgc00261186-01
61. 2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine;hydrochloride
62. Db-040850
63. Cs-0013220
64. E0799
65. Ft-0631049
66. Ft-0700527
67. Sw220223-1
68. Epinastine Hydrochloride [orange Book]
69. D01713
70. Epinastine Hydrochloride [ep Monograph]
71. F17420
72. Epinastine Hydrochloride, >=98% (hplc), Solid
73. A857231
74. J-002209
75. Q27122286
76. Epinastine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
77. 1h-dibenz(c,f)imidazo(1,5-a)azepin-3-amine, 9,13b-dihydro-, Hydrochloride (1:1)
78. 3-amino-9,13b-dihydro-1h-dibenz(c,f)imidazo(1,5-a)azepine Hydrochloride, Dl-
79. Epinastine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
80. 2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine;hydron;chloride
81. Epinastine Hydrochloride For System Suitability, European Pharmacopoeia (ep) Reference Standard
Molecular Weight | 285.77 g/mol |
---|---|
Molecular Formula | C16H16ClN3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 0 |
Exact Mass | 285.1032752 g/mol |
Monoisotopic Mass | 285.1032752 g/mol |
Topological Polar Surface Area | 41.6 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 378 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Elestat |
PubMed Health | Epinastine (Into the eye) |
Drug Classes | Ophthalmologic Agent |
Drug Label | ELESTAT (epinastine HCl ophthalmic solution) 0.05% is a clear, colorless, sterile isotonic solution containing epinastine HCl, an antihistamine and an inhibitor of histamine release from the mast cell for topical administration to the eyes. Epinast... |
Active Ingredient | Epinastine hydrochloride |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 0.05% |
Market Status | Prescription |
Company | Allergan |
2 of 4 | |
---|---|
Drug Name | Epinastine hydrochloride |
Drug Label | Epinastine HCl ophthalmic solution, 0.05% is a clear, colorless, sterile isotonic solution containing epinastine HCl, an antihistamine and an inhibitor of histamine release from the mast cell for topical administration to the eyes.Epinastine HCl is r... |
Active Ingredient | Epinastine hydrochloride |
Dosage Form | Solution/drops; Solution |
Route | ophthalmic; Ophthalmic |
Strength | 0.05% |
Market Status | Tentative Approval; Prescription |
Company | Tesa Pharms; Breckenridge Pharm; Apotex; Sun Pharm Inds; Sandoz |
3 of 4 | |
---|---|
Drug Name | Elestat |
PubMed Health | Epinastine (Into the eye) |
Drug Classes | Ophthalmologic Agent |
Drug Label | ELESTAT (epinastine HCl ophthalmic solution) 0.05% is a clear, colorless, sterile isotonic solution containing epinastine HCl, an antihistamine and an inhibitor of histamine release from the mast cell for topical administration to the eyes. Epinast... |
Active Ingredient | Epinastine hydrochloride |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 0.05% |
Market Status | Prescription |
Company | Allergan |
4 of 4 | |
---|---|
Drug Name | Epinastine hydrochloride |
Drug Label | Epinastine HCl ophthalmic solution, 0.05% is a clear, colorless, sterile isotonic solution containing epinastine HCl, an antihistamine and an inhibitor of histamine release from the mast cell for topical administration to the eyes.Epinastine HCl is r... |
Active Ingredient | Epinastine hydrochloride |
Dosage Form | Solution/drops; Solution |
Route | ophthalmic; Ophthalmic |
Strength | 0.05% |
Market Status | Tentative Approval; Prescription |
Company | Tesa Pharms; Breckenridge Pharm; Apotex; Sun Pharm Inds; Sandoz |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)